The lncRNA SUMO1P3 enhances proliferation, invasiveness, and drug resistance in gastric cancer cell lines by directly binding to CNBP, resulting in high levels of c-myc and cyclinD1 (CCND1) (Guo et al., 2020). Here, SUMO1P3 is linked to gastric cancer.